Literature DB >> 30775980

The Role of Apolipoprotein E Isoforms in Alzheimer's Disease.

Alejandro R Roda1, Laia Montoliu-Gaya1,2, Sandra Villegas1.   

Abstract

Alzheimer's disease (AD), the most common type of dementia worldwide, is characterized by high levels of amyloid-β (Aβ) peptide and hyperphosphorylated tau protein. Genetically, the ɛ4 allele of apolipoprotein E (ApoE) has been established as the major risk factor for developing late-onset AD (LOAD), the most common form of the disease. Although the role ApoE plays in AD is still not completely understood, a differential role of its isoforms has long been known. The current review compiles the involvement of ApoE isoforms in amyloid-β protein precursor transcription, Aβ aggregation and clearance, synaptic plasticity, neuroinflammation, lipid metabolism, mitochondrial function, and tau hyperphosphorylation. Due to the complexity of LOAD, an accurate description of the interdependence among all the related molecular mechanisms involved in the disease is needed for developing successful therapies.

Entities:  

Keywords:  AICD generation; Alzheimer’s disease; Aβ aggregation; Aβ clearance; AβPP transcription; amyloid-β; apolipoprotein E; lipid metabolism; mitochondrial damage; neuroinflammation

Year:  2019        PMID: 30775980     DOI: 10.3233/JAD-180740

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

2.  Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.

Authors:  Chuan He; Zhong-Sheng Huang; Chao-Chao Yu; Hai-Hua Wang; Hua Zhou; Li-Hong Kong
Journal:  Curr Med Sci       Date:  2021-01-11

3.  In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (Aβ) Complex at Different pH Conditions.

Authors:  Jorge Alberto Aguilar-Pineda; Silvana G Paco-Coralla; Camilo Febres-Molina; Pamela L Gamero-Begazo; Pallavi Shrivastava; Karin J Vera-López; Gonzalo Davila-Del-Carpio; Patricia López-C; Badhin Gómez; Christian L Lino Cardenas
Journal:  Biomolecules       Date:  2022-03-25

4.  Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype.

Authors:  Jing Guo; Adam M Brickman; Jennifer J Manly; Christiane Reitz; Nicole Schupf; Richard P Mayeux; Yian Gu
Journal:  Alzheimers Dement       Date:  2021-05-02       Impact factor: 21.566

5.  The risk of dementia after coronary artery bypass grafting in relation to age and sex.

Authors:  Kok Wai Giang; Anders Jeppsson; Martin Karlsson; Emma C Hansson; Aldina Pivodic; Ingmar Skoog; Martin Lindgren; Susanne J Nielsen
Journal:  Alzheimers Dement       Date:  2021-03-04       Impact factor: 21.566

Review 6.  APOE-amyloid interaction: Therapeutic targets.

Authors:  Thomas Wisniewski; Eleanor Drummond
Journal:  Neurobiol Dis       Date:  2020-02-04       Impact factor: 5.996

Review 7.  ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.

Authors:  Maria Fe Lanfranco; Christi Anne Ng; G William Rebeck
Journal:  Int J Mol Sci       Date:  2020-09-01       Impact factor: 5.923

Review 8.  Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease.

Authors:  Alejandro R Roda; Gabriel Serra-Mir; Laia Montoliu-Gaya; Lidia Tiessler; Sandra Villegas
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

Review 9.  Passive immunotherapies targeting Aβ and tau in Alzheimer's disease.

Authors:  Steven S Plotkin; Neil R Cashman
Journal:  Neurobiol Dis       Date:  2020-07-16       Impact factor: 7.046

10.  Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.

Authors:  Makoto Hashimoto; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Shuei Sugama; Takato Takenouchi; Masaaki Waragai; Eliezer Masliah
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.